Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging therapies in malignant pleural mesothelioma.
Cinausero M, Rihawi K, Cortiula F, Follador A, Fasola G, Ardizzoni A. Cinausero M, et al. Among authors: rihawi k. Crit Rev Oncol Hematol. 2019 Dec;144:102815. doi: 10.1016/j.critrevonc.2019.102815. Epub 2019 Oct 5. Crit Rev Oncol Hematol. 2019. PMID: 31670225 Review.
Determinants of Last-line Treatment in Metastatic Breast Cancer.
Cinausero M, Gerratana L, De Carlo E, Iacono D, Bonotto M, Fanotto V, Buoro V, Basile D, Vitale MG, Rihawi K, Fasola G, Puglisi F. Cinausero M, et al. Among authors: rihawi k. Clin Breast Cancer. 2018 Jun;18(3):205-213. doi: 10.1016/j.clbc.2017.07.008. Epub 2017 Jul 14. Clin Breast Cancer. 2018. PMID: 28781022
Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins.
Rihawi K, Cinausero M, Fiorentino M, Salvagni S, Brocchi S, Ardizzoni A. Rihawi K, et al. J Thorac Oncol. 2018 Mar;13(3):e41-e43. doi: 10.1016/j.jtho.2017.10.024. J Thorac Oncol. 2018. PMID: 29472059 Free article. No abstract available.
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale.
Andrini E, Lamberti G, Mazzoni F, Riccardi F, Bonetti A, Follador A, Artioli F, Genova C, Barbieri F, Frassoldati A, Brighenti M, Colantonio I, Pasello G, Ficorella C, Cinieri S, Tiseo M, Gelsomino F, Tognetto M, Rihawi K, Ardizzoni A. Andrini E, et al. Among authors: rihawi k. Future Oncol. 2022 Mar;18(7):771-779. doi: 10.2217/fon-2021-1027. Epub 2022 Jan 24. Future Oncol. 2022. PMID: 35068173
45 results